Global Automated External Defibrillator Market Volume Forecast and Value Chain Analysis 2025 by Million Insights

on

20th November 2018: Global Automated External Defibrillator (AED) market is expected to grow rapidly over the forecast period. These are transportable electronic devices which automatically detects and identifies cardiovascular diseases in patients and cure them through defibrillation. In sudden cardiac arrest, heartbeat stops suddenly and might result in death. Yet, it is different from a heart attack. The heart stops beating as its electrical system gets affected in a sudden cardiac arrest. While, a heart attack occurs due to blockage in the blood vessels which results in the disturbance in blood flow. Hence, an automated external defibrillator gives an electric shock to bring back the regular cardiac rhythm of the patient.
Major factor driving the global automated external defibrillator market include rising occurrences of cardiovascular diseases and increased geriatric population. Other factors which boost the market demand are changing demographics, increased levels of stress, pollution, inadequate eating habits and work station exposure to dangerous compounds such as extreme cold, smoke and lead.  Few healthcare regulatory agencies such as Medicare and Medicaid Services, the CDC, Agency for Healthcare Research and Quality and European Heart Agency have taken initiatives which is expected to benefit the overall demand for automated external defibrillator over the next seven years. Furthermore, extensive availability of medical amenities for patients suffering from sudden cardiac arrest and development in medical technology also drive the overall market. Rising installations of publically accessible AED, increasing awareness about the lifesaving prospective of AED and growth in the number of patients suffering from sudden cardiac arrests have also supported in the increase in market size of AEDs.
Global automated external defibrillator market is segmented based on technology and end user. On the basis of technology, it is classified as semi-automated and fully automated external defibrillators. On the basis of end user, the market is segmented into five categories namely, hospitals, pre hospitals, public access, alternate care and home. Automated external defibrillators play a vital role in saving the lives of patients suffering from sudden cardiac arrest. Bearing this potential in mind, legislations have been passed which require installations of public access defibrillators (PAD) in Japan, the U.S. and some European countries. The external cardiac defibrillators is one of the fastest emerging segment while internal/implantable cardiac defibrillators segment is one of the largest segment. Rising awareness in the health care segment of The U.S. also accounts for the growth in external cardiac defibrillators.
Major industry participants are investing in research & development to come up with innovative production techniques to cater to the existing hindrances in the market. Major industry participants include Boston Scientific Corporation, Defibtech, General Electric Company, HeartSine Tehnologies Inc., Koninklijke Philips N.V., Cardiac Science Inc., Biotronik GmbH & Co. KG, Nihon Kohden Corporation, St. Jude Medical Inc., Welch Allyn, GE Healthcare Ltd., Sorin SpA, Medtronic Inc., Philips Healthcare and ZOLL Medical Corporation. Boston Scientific Corporation is ground breaking in innovating and quick introduction of highly advanced FDA accepted products. In 2014, it launched Inogen X4 CRT-D and Dynagen X4 device that was intended for higher PNS threshold, prolonged battery life and easier placement. ZOLL Medical Corporation provides an exclusive light weight wearable external defibrillator (LifeVest) on provisional basis by patients suffering from long-term arrhythmic condition, to let physicians precisely evaluate the condition and make well informed decisions without conceding on the safety of the patient.   

Comments

Post a Comment